发明授权
- 专利标题： Acetyl CoA carboxylase 2 sequences and methods
- 专利标题（中）： 乙酰CoA羧化酶2序列和方法
-
申请号： US11186999申请日： 2005-07-21
-
公开(公告)号： US07211423B2公开(公告)日： 2007-05-01
- 发明人: Dong Cheng , John N. Feder , Luping Chen , Ching-Hsuen Chu
- 申请人： Dong Cheng , John N. Feder , Luping Chen , Ching-Hsuen Chu
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Co.
- 当前专利权人： Bristol-Myers Squibb Co.
- 当前专利权人地址： US NJ Princeton
- 代理商 Brian C. Carey
- 主分类号： C12N9/10
- IPC分类号： C12N9/10 ; C12N15/70 ; C12N1/20 ; C12N5/16 ; C12Q1/68 ; C12P21/06 ; C07H21/04
摘要：
The present invention relates generally to novel nucleotide and amino acid sequences, and more particularly to novel human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences provided herein can be expressed in a recombinant format. Methods of isolating the ACC2 sequence are also provided, which can be employed to isolate any ACC sequence. The ACC2 sequences can be employed in therapeutic applications to diagnose or treat a condition associated with ACC2. The invention also relates to the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as the screening target.
公开/授权文献
- US20060019364A1 Acetyl CoA carboxylase 2 sequences and methods 公开/授权日：2006-01-26